Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Read this State-of-the-Art review in #EHJ 👉 https://t.co/izTvcZQG42 @RoccoMontone @ehj_ed

🚀 Calcium Score & CCTA: Key Highlights from the 2025 AHA Scientific Statement (DOI: 10.1161/CIR.0000000000001394) Non-obstructive CAD in Chest Pain Patients 🧊 1. CAC = Atherosclerotic Burden, Not Just a Number CAC is one of the strongest predictors of future ASCVD risk—better

OPTIMA-AF Trial #AHA2025 In 1,079 patients with atrial fibrillation undergoing PCI, 1 month of dual antithrombotic therapy (DOAC + P2Y12 inhibitor) followed by DOAC alone was non-inferior to 12 months of dual therapy for death, MI, or stroke (5.4 % vs 4.5 %). It also

ADAPT AF-DES trial: In patients with AF and stable CAD >1 year after DES implantation, DOAC monotherapy was non-inferior to DOAC + clopidogrel for net adverse clinical events at 12 months, driven by reduced bleeding risk. #AHA25 View the slides here: https://t.co/cjeMwRoySr

La droga más famosa del mundo contra la obesidad llegó a la Argentina: venta bajo receta y eficacia en adultos y adolescentes desde 12 años - Infobae

https://t.co/ishbBoxcBs

Tremendous crowd waiting for the keynote lecture from Dr Fuster on this 50th anniversary of #favaloroFoundation ⁦@MountSinaiNYC⁩ ⁦@IcahnMountSinai⁩ ⁦@ACCinTouch⁩

Presented at #ESCCongress: In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results:

NEW #ESCGuidelines on #myocarditis and #pericarditis: https://t.co/SgQdjRLjDY

La medición de la presión arterial bajo la lupa: por qué el método con brazalete puede fallar - Infobae

Could administering heparin at first medical contact improve outcomes in STEMI treatment? Read the results of HELP-PCI trial in #EHJ. https://t.co/XIrhS5ntA7 #STEMI #primaryPCI #cardiotwitter @ESC_Journals @escardio.

📌 Do statins play a role in primary CVD prevention among apparently healthy adults? 🔍 New evidence from a large Danish cohort study—read more ⬇️ https://t.co/RzFtdAnM6M @EJPCEiC @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @justvick

René Favaloro, el hombre que pensó en el corazón argentino y terminó revolucionando la medicina del mundo - Infobae

#ArtificialIntelligence analysis of the single-lead ECG predicts long-term clinical outcomes https://t.co/HQTAIhYzow #EHJDigital #mHealth @BruiningNico @rafavidalperez @fwasselbergs @rbcasado

https://t.co/zt8RLY3KBj

.Nice session at @ComunidadFAC congress in Mendoza, Argentina. Wonderful lecture @Drroxmehran. Hope to see soon al Favaloro Cardiovasvular Symposium in September @SAC_54 @FundFavaloro

https://t.co/FFqL3z3wzh @FundFavaloro @SAC_54 @ComunidadFAC

.Presentación de Tenecteplase en Argentina. Fibrinolitico de facil administración en bolo rápido. Va a cambiar la historia del infarto en nuestro país acortando los tiempos a la reperfusión y salvando vidas @BoehringerSA @GerardoOZapata @alfocandiello @SAC_54 @ComunidadFAC

🔴Association Between Coronary Artery Spasm and Atherosclerotic Disease ⤵️ State of the Art #2025Review #openaccess @JACCJournals 🔹 https://t.co/6K6EAzFDd7

Efficacy of Colchicine in Reducing Major Adverse Cardiovascular Events: a Meta-Analysis of Randomized Controlled Trials! https://t.co/ivTczqUtGf #EHJ #cardiotwitter #colchicine #ischaemia #stroke @ESC_journals @escardio